Beck Long shared Tom’s journey with myeloma on The Morning Show to highlight the importance of funding research into blood cancers. The interview is heartfelt and highlights that perhaps the outcome for Tom would have been different if he was able to access new treatments in Australia. Aussie actor Tom Long lost his long battle … Continued
The Australian featured an exclusive story on the remarkable insights provided by genomic testing. To quote Dr Piers Blombery, Head of the Molecular Haematology Laboratory at the Peter MacCallum Cancer Centre,“Every cancer is different and genomics testing such as the ctDNA panel gives clinicians more details about what drives the individual patient’s tumour cells; it … Continued
We have been living with the COVID 19 pandemic for 6 months now. Our knowledge about the virus and who is most at risk has grown dramatically. Prof Miles Prince shares with us key learnings, what your risks are as a blood cancer patient and how to prepare should someone you live with get diagnosed. … Continued
In the lead up World Blood Donor Day co-founder Grant Rutherford speaks to The Daily Edition about how the tragic loss of his daughter Chloe to leukaemia led to the formation of the Snowdome Foundation 10 years ago.
Barry Du Bois featured on Studio 10 to support the Snowdome Foundation and raise awareness for blood cancer. He emphasised the importance of funding research and clinical trials in order to find better treatments. With World Blood Donor Day on June 14 he wanted people to help by donating blood or donating funds to Snowdome.
We are incredibly proud to announce that the Snowdome Foundation in conjunction with Maddie Riewoldt’s Vision ranked number 266 in the Top 500 high growth companies in Asia Pacific. To quote Maxine Kelly, from The Financial Times “While the data in the table does not take into account the unfolding Coronavirus, it could help to identify those … Continued
Snowdome Foundation took the opportunity to film Prof Miles Prince AM as he spoke about his advice to blood cancer patients during COVID 19. We hope you find this video useful and reassuring. Please click on the image to hear what Miles had to say.
The Medical Services Advisory Committee (MSAC) has given a positive recommendation to Kymriah a CAR T-cell therapy to treat refractory or relapsed diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) including transformed, and primary mediastinal B-cell lymphoma (PMBCL). The treatment would cost an individual up to $500,000 but will now be funded by the government. In … Continued
Wonderful to see the FDA, TGA and Canadian regulatory authorities working together to approve a new treatment for refractory/ relapsed Chronic Lymphocytic Leukaemia (CLL). Acalabrutinib is a second-generation BTK (Bruton’s tyrosine kinase or tyrosine-protein kinase) and was shown to be more effective and more tolerable than usual treatments. We look forward to seeing this treatment … Continued